Filing Details
- Accession Number:
- 0001179110-17-012991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-03 17:03:29
- Reporting Period:
- 2017-10-02
- Accepted Time:
- 2017-10-03 17:03:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1586105 | Egalet Corp | EGLT | Pharmaceutical Preparations (2834) | 463575334 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599219 | Mark Strobeck | 600 Lee Road Suite 100 Wayne PA 19087 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-10-02 | 8,700 | $1.29 | 12,080 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on February 11, 2014.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
